Log in
NASDAQ:NTLA

Intellia Therapeutics News Headlines

$23.51
+1.06 (+4.72 %)
(As of 09/19/2020 01:34 AM ET)
Add
Compare
Today's Range
$22.85
Now: $23.51
$23.90
50-Day Range
$17.47
MA: $19.90
$22.97
52-Week Range
$9.18
Now: $23.51
$25.56
Volume2.46 million shs
Average Volume835,917 shs
Market Capitalization$1.38 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.69

Headlines

Intellia Therapeutics (NASDAQ NTLA) News Headlines Today

Source:
DateHeadline
Intellia Therapeutics (NASDAQ:NTLA) Now Covered by Analysts at Goldman Sachs GroupIntellia Therapeutics (NASDAQ:NTLA) Now Covered by Analysts at Goldman Sachs Group
marketbeat.com - September 18 at 7:30 AM
Intellia Therapeutics (NASDAQ:NTLA) Lifted to Hold at BidaskClubIntellia Therapeutics (NASDAQ:NTLA) Lifted to Hold at BidaskClub
marketbeat.com - August 20 at 5:28 AM
Intellia Therapeutics (NASDAQ:NTLA) Hits New 52-Week High on Analyst UpgradeIntellia Therapeutics (NASDAQ:NTLA) Hits New 52-Week High on Analyst Upgrade
marketbeat.com - June 3 at 10:56 AM
Intellia Therapeutics trades high post Goldman Sachs Buy initiationIntellia Therapeutics trades high post Goldman Sachs Buy initiation
seekingalpha.com - September 18 at 1:23 PM
Intellia Therapeutics (NASDAQ:NTLA) Earns Buy Rating from Analysts at Goldman Sachs GroupIntellia Therapeutics (NASDAQ:NTLA) Earns Buy Rating from Analysts at Goldman Sachs Group
americanbankingnews.com - September 18 at 8:27 AM
Intellia Therapeutics Inc (NASDAQ:NTLA) EVP Sells $118,139.60 in StockIntellia Therapeutics Inc (NASDAQ:NTLA) EVP Sells $118,139.60 in Stock
americanbankingnews.com - September 17 at 6:53 PM
Intellia Therapeutics (NASDAQ:NTLA) Stock Price Up 6.5%Intellia Therapeutics (NASDAQ:NTLA) Stock Price Up 6.5%
americanbankingnews.com - September 15 at 7:28 PM
Intellia Therapeutics (NASDAQ:NTLA) Trading Up 7.7%Intellia Therapeutics (NASDAQ:NTLA) Trading Up 7.7%
americanbankingnews.com - September 9 at 7:05 PM
Contrasting Intellia Therapeutics (NASDAQ:NTLA) and Biomerica (NASDAQ:BMRA)Contrasting Intellia Therapeutics (NASDAQ:NTLA) and Biomerica (NASDAQ:BMRA)
americanbankingnews.com - September 8 at 10:38 PM
Intellia Therapeutics to Present at Bairds 2020 Virtual Global Healthcare ConferenceIntellia Therapeutics to Present at Baird's 2020 Virtual Global Healthcare Conference
marketwatch.com - September 4 at 7:35 PM
Intellia Therapeutics (NASDAQ:NTLA) Trading Down 13.4%Intellia Therapeutics (NASDAQ:NTLA) Trading Down 13.4%
americanbankingnews.com - September 3 at 10:01 PM
Intellia Therapeutics to Present at Baird’s 2020 Virtual Global Healthcare ConferenceIntellia Therapeutics to Present at Baird’s 2020 Virtual Global Healthcare Conference
finance.yahoo.com - September 2 at 10:19 AM
How Much Of Intellia Therapeutics, Inc. (NASDAQ:NTLA) Do Institutions Own?How Much Of Intellia Therapeutics, Inc. (NASDAQ:NTLA) Do Institutions Own?
finance.yahoo.com - August 11 at 5:04 PM
We're Not Worried About Intellia Therapeutics' (NASDAQ:NTLA) Cash BurnWe're Not Worried About Intellia Therapeutics' (NASDAQ:NTLA) Cash Burn
finance.yahoo.com - August 11 at 5:04 PM
Intellia Therapeutics (NTLA) CEO Ernest Garcia on Q2 2020 Results - Earnings Call TranscriptIntellia Therapeutics (NTLA) CEO Ernest Garcia on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 2:35 PM
Intellia Therapeutics (NTLA) CEO John Leonard on Q2 2020 Results - Earnings Call TranscriptIntellia Therapeutics (NTLA) CEO John Leonard on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 2:35 PM
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Tops Revenue EstimatesIntellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 6 at 2:35 PM
Intellia Therapeutics EPS beats by $0.09, beats on revenueIntellia Therapeutics EPS beats by $0.09, beats on revenue
seekingalpha.com - August 6 at 9:27 AM
Intellia Therapeutics Announces Second Quarter 2020 Financial ResultsIntellia Therapeutics Announces Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 9:27 AM
Intellia Therapeutics Q2 2020 Earnings PreviewIntellia Therapeutics Q2 2020 Earnings Preview
seekingalpha.com - August 5 at 12:59 PM
Intellia Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceIntellia Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 3 at 12:53 PM
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q2 Earnings Expected to DeclineEarnings Preview: Intellia Therapeutics, Inc. (NTLA) Q2 Earnings Expected to Decline
finance.yahoo.com - July 30 at 3:33 PM
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company UpdatesIntellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company Updates
finance.yahoo.com - July 30 at 10:33 AM
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company UpdatesIntellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company Updates
finance.yahoo.com - July 30 at 10:33 AM
INTELLIA THERAPEU DL-,01 (38I.DU)INTELLIA THERAPEU DL-,01 (38I.DU)
au.finance.yahoo.com - July 27 at 12:17 AM
MeiraGTx Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaMeiraGTx Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 20 at 10:38 PM
Intellia Therapeutics partners with GEMoaB to develop immunotherapiesIntellia Therapeutics partners with GEMoaB to develop immunotherapies
seekingalpha.com - July 20 at 12:35 PM
Intellia Therapeutics, Inc. (NTLA): Hedge Funds Taking Some Chips Off The TableIntellia Therapeutics, Inc. (NTLA): Hedge Funds Taking Some Chips Off The Table
finance.yahoo.com - July 5 at 11:29 PM
Intellia Therapeutics Announces Second Quarter 2017 Financial ResultsIntellia Therapeutics Announces Second Quarter 2017 Financial Results
www.bloomberg.com - June 24 at 10:00 PM
Intellia closes $115M capital raiseIntellia closes $115M capital raise
seekingalpha.com - June 5 at 5:54 PM
Intellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesIntellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 5 at 5:54 PM
Edited Transcript of NTLA earnings conference call or presentation 7-May-20 12:00pm GMTEdited Transcript of NTLA earnings conference call or presentation 7-May-20 12:00pm GMT
finance.yahoo.com - June 4 at 5:05 AM
Biotech Stock Roundup: GILDs Coronavirus Drug Update, NTLA-REGN Deal & MoreBiotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More
finance.yahoo.com - June 3 at 12:23 PM
Intellia Therapeutics prices equity offering at $18.25Intellia Therapeutics prices equity offering at $18.25
seekingalpha.com - June 3 at 7:22 AM
Why Editas Medicine Is Now the CRISPR Stock to Really WatchWhy Editas Medicine Is Now the CRISPR Stock to Really Watch
finance.yahoo.com - June 3 at 7:22 AM
Intellia launches $75M equity offeringIntellia launches $75M equity offering
seekingalpha.com - June 1 at 6:21 PM
Intellia Therapeutics Announces Proposed Public Offering of Common StockIntellia Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 1 at 6:21 PM
Regeneron Expands Existing Collaboration With Intellia - Quick FactsRegeneron Expands Existing Collaboration With Intellia - Quick Facts
www.nasdaq.com - June 1 at 8:16 AM
Regeneron and Intellia expand partnership into hemophiliaRegeneron and Intellia expand partnership into hemophilia
seekingalpha.com - June 1 at 8:16 AM
Heres Why Editas Could Beat Intellia to a CRISPR TherapyHere's Why Editas Could Beat Intellia to a CRISPR Therapy
www.fool.com - May 22 at 12:43 PM
Here's Why Editas Could Beat Intellia to a CRISPR TherapyHere's Why Editas Could Beat Intellia to a CRISPR Therapy
finance.yahoo.com - May 22 at 12:43 PM
Intellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate DevelopmentsIntellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Developments
www.bloomberg.com - May 22 at 12:57 AM
Intellia Therapeutics Sees Relative Strength Rating Rise To 92 Amid Cancer Treatment DevelopmentIntellia Therapeutics Sees Relative Strength Rating Rise To 92 Amid Cancer Treatment Development
finance.yahoo.com - May 18 at 8:39 PM
BRIEF-Intellia Reports Progress On Crispr/CAS9 AML Cancer TherapyBRIEF-Intellia Reports Progress On Crispr/CAS9 AML Cancer Therapy
www.reuters.com - May 12 at 8:10 AM
Intellia employs novel gene editing approach to improve AML candidateIntellia employs novel gene editing approach to improve AML candidate
seekingalpha.com - May 12 at 8:10 AM
Intellia Therapeutics Reports Progress on CRISPR/Cas9 AML Cancer Therapy Using Proprietary Cell Engineering Process at the 23rd Annual Meeting of the American Society of Gene and Cell TherapyIntellia Therapeutics Reports Progress on CRISPR/Cas9 AML Cancer Therapy Using Proprietary Cell Engineering Process at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy
finance.yahoo.com - May 12 at 8:09 AM
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportIntellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
finance.yahoo.com - May 11 at 7:56 AM
Intellia Therapeutics, Inc. (NTLA) Q1 2020 Earnings Call TranscriptIntellia Therapeutics, Inc. (NTLA) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 9 at 5:02 PM
Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q1 2020 Results - Earnings Call TranscriptIntellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 1:15 AM
Recap: Intellia Therapeutics Q1 EarningsRecap: Intellia Therapeutics Q1 Earnings
finance.yahoo.com - May 7 at 3:14 PM
Intellia Therapeutics Inc (NTLA) Reports Q1 Loss, Misses Revenue EstimatesIntellia Therapeutics Inc (NTLA) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 7 at 3:14 PM
Intellia Therapeutics EPS misses by $0.11, misses on revenueIntellia Therapeutics EPS misses by $0.11, misses on revenue
seekingalpha.com - May 7 at 9:37 AM
BRIEF-Intellia Therapeutics Inc - QTRLY Dhr Loss $0.63BRIEF-Intellia Therapeutics Inc - QTRLY Dhr Loss $0.63
www.reuters.com - May 7 at 9:37 AM
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.